2661 — QingSong Health Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.99bn
- HK$3.89bn
- CNY1.26bn
Annual cashflow statement for QingSong Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -2.09 | 73.6 | 10.4 | -380 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 166 | 47.1 | 52.9 | 410 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -112 | -118 | 15.5 | 47.1 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 57.2 | 7.83 | 83.8 | 82.1 |
| Capital Expenditures | 0 | -0.181 | -1 | -0.716 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -94.9 | -4.71 | 17.5 | -21.5 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -94.9 | -4.89 | 16.5 | -22.2 |
| Financing Cash Flow Items | 0 | 0 | -26.1 | 518 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -4.99 | -4.95 | -30.6 | 439 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -42 | -2.39 | 69.4 | 499 |